Skip to main content

Cheek Wrinkles

0
Pipeline Programs
1
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
4 programs
GP0112N/A1 trial
GP0112N/A1 trial
Sculptra Aesthetic new dilutionN/A1 trial
Sculptra®N/A1 trial
Active Trials
NCT05262777Completed211Est. Mar 2024
NCT05098457Withdrawn0Est. Nov 2023
NCT04124692Completed149Est. Aug 2021
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GaldermaSculptra®
GaldermaGP0112
GaldermaGP0112
GaldermaSculptra Aesthetic new dilution

Clinical Trials (4)

Total enrollment: 400 patients across 4 trials

NCT07342400GaldermaSculptra®

A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages

Start: Aug 2025Est. completion: Nov 202640 patients
N/ARecruiting
NCT05262777GaldermaGP0112

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Start: May 2022Est. completion: Mar 2024211 patients
N/ACompleted
NCT05098457GaldermaGP0112

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction

Start: Feb 2022Est. completion: Nov 20230
N/AWithdrawn
NCT04124692GaldermaSculptra Aesthetic new dilution

Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles

Start: Nov 2019Est. completion: Aug 2021149 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 400 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.